Results 41 to 50 of about 348,699 (383)

Pollen grains induce a rapid and biphasic eczematous immune response in atopic eczema patients [PDF]

open access: yes, 2008
Introduction: Eczematous reactions to type I allergy-inducing antigens are documented in a subgroup of patients with atopic eczema. Yet, the underlying immunological mechanisms are not well understood.
Behrendt, Heidrun   +7 more
core   +2 more sources

Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND Nemolizumab is a subcutaneously administered humanized monoclonal antibody against interleukin-31 receptor A, which is involved in pruritus and inflammation in atopic dermatitis.
K. Kabashima   +3 more
semanticscholar   +1 more source

Nomenclature and clinical phenotypes of atopic dermatitis

open access: yesTherapeutic Advances in Chronic Disease, 2021
Atopic dermatitis is a heterogeneous disease and resists classification. In this review, we discuss atopic dermatitis nomenclature and identify morphologic phenotypes, which will facilitate correct diagnoses and development of treatment strategies.
G. Girolomoni   +7 more
semanticscholar   +1 more source

A Microbiome-Based Index for Assessing Skin Health and Treatment Effects for Atopic Dermatitis in Children. [PDF]

open access: yes, 2019
A quantitative and objective indicator for skin health via the microbiome is of great interest for personalized skin care, but differences among skin sites and across human populations can make this goal challenging.
Callewaert, Chris   +15 more
core   +4 more sources

JAK3 as an emerging target for topical treatment of inflammatory skin diseases [PDF]

open access: yes, 2016
The recent interest and elucidation of the JAK/STAT signaling pathway created new targets for the treatment of inflammatory skin diseases (ISDs). JAK inhibitors in oral and topical formulations have shown beneficial results in psoriasis and alopecia ...
Alves de Medeiros, Ana   +5 more
core   +4 more sources

Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*

open access: yesBritish Journal of Dermatology, 2020
Tralokinumab is a fully human monoclonal antibody that specifically neutralizes interleukin‐13, a key driver of atopic dermatitis (AD).
J. Silverberg   +11 more
semanticscholar   +1 more source

Emerging Methods to Objectively Assess Pruritus in Atopic Dermatitis. [PDF]

open access: yes, 2019
INTRODUCTION:Atopic dermatitis (AD) is an inflammatory skin disease with a chronic, relapsing course. Clinical features of AD vary by age, duration, and severity but can include papules, vesicles, erythema, exudate, xerosis, scaling, and lichenification.
Bhutani, Tina   +7 more
core   +1 more source

Sensitizing agents found in children and adolescents with recalcitrant atopic dermatitis: a cross-sectional study with a pediatric battery [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2022
Background Atopic dermatitis is the most common inflammatory skin disease in childhood and has an important impact on quality of life, especially severe cases or those that are recalcitrant to treatments. Sensitization to allergens with the potential for
Cristiane Almeida Soares Cattani   +5 more
doaj   +1 more source

Atopic Dermatitis and Comorbidity [PDF]

open access: yesHealthcare, 2020
Atopic dermatitis is the most common chronic inflammatory skin disease. It is often the first indicator of allergic diseases, and a certain percentage of patients are affected by allergic rhinitis and/or asthma as a consequence. The study aimed to investigate the link between atopic dermatitis and comorbidity in family medicine.
Sanja Bekić   +5 more
openaire   +3 more sources

Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy

open access: yesExpert review of pharmacoeconomics & outcomes research, 2020
Introduction Asthma, allergic rhinitis, atopic dermatitis, and food allergy affect approximately 20% of the global population. Few studies describe the burden of the totality of these diseases and only a handful studies provide a comprehensive overview ...
B. Dierick   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy